$14.36
0.080.56%
Last update: Oct 23, 1:02 AM
HUTCHMED (China) Ltd (HCM) Stock Price, Quote, News & History
HCMNASDAQ
HUTCHMED stock jumps on a $1.3B GSK deal for its cancer drug HMPL-A830. Learn the financial terms and key global rights split.
You can purchase shares of HUTCHMED (China) (NASDAQ:HCM) through any online brokerage.
Other companies in HUTCHMED (China)’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
HUTCHMED (China) has a consensus price target of $17.37.
The stock price for HUTCHMED (China) (NASDAQ: HCM) is $14.28 last updated October 23, 2026 at 1:02 AM EDT.
There are no upcoming dividends for HUTCHMED (China).
HUTCHMED (China) does not have any upcoming earnings scheduled.
There is no upcoming split for HUTCHMED (China).
HUTCHMED (China) is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several...
